Gemcitabine, Cisplatin, Plus Lenalidomide as First-line Therapy for Patients With Metastatic Urothelial Carcinoma - Full Text...
Karnofsky Performance Status of ≥ 70%.. *Histological or cytological proof of transitional cell carcinoma of the urothelial ...https://clinicaltrials.gov/ct2/show/NCT01342172
Trial of Adjuvant Chemotherapy for High Risk Gastric Cancer Patients - Full Text View - ClinicalTrials.gov
Karnofsky performance status scale ≥ 70;. *prior adjuvant chemotherapy that did not include taxanes and S-1; ... Recruitment Status : Unknown Verified May 2012 by Tianjin Medical University Cancer Institute and Hospital. Recruitment status ...https://clinicaltrials.gov/ct2/show/NCT01618474
Bevacizumab in Reducing CNS Side Effects in Patients Who Have Undergone Radiation Therapy to the Brain for Primary Brain Tumor,...
Karnofsky performance status 60-100%. * No clinically significant cardiovascular disease, including any of the following:. * ...https://clinicaltrials.gov/ct2/show/NCT00492089?cond=%22Anaplastic+ependymoma%22&rank=16
Tretinoin and Arsenic Trioxide With or Without Idarubicin in Treating Patients With Acute Promyelocytic Leukemia - Full Text...
Karnofsky performance status 60-100%. *Creatinine ≤ 2.0 mg/dL or creatinine clearance , 60 mL/min ...https://clinicaltrials.gov/show/NCT00528450
Depsipeptide (Romidepsin) in Treating Patients With Metastatic or Unresectable Soft Tissue Sarcoma - Full Text View -...
Performance status - Eastern Cooperative Oncology Group (ECOG) 0-2. *Performance status - Karnofsky 50-100% ...https://clinicaltrials.gov/ct2/show/NCT00112463?cond=%22Epithelioid+sarcoma%22&rank=6
Bevacizumab and Cetuximab With or Without Irinotecan in Treating Patients With Irinotecan-Refractory Metastatic Colorectal...
Performance status - ECOG 0-1. *Performance status - Karnofsky 80-100%. *More than 3 months ... Patients are stratified according to participating center, ECOG performance status (0 vs 1), and albumin (, 3.0 g/dL vs ≤ 3.0 g ...https://clinicaltrials.gov/ct2/show/NCT00077298
Vaccine Therapy in Preventing HPV in HIV-Positive Women in India - Full Text View - ClinicalTrials.gov
Karnofsky performance status 70-100%. *ANC , 750 cells/mm³. *Hemoglobin ≥ 9.0 g/dL ...https://clinicaltrials.gov/show/NCT00667563?order=49
Comparison of Radiation Therapy Regimens in Combination With Chemotherapy in Treating Young Patients With Newly Diagnosed...
Performance status - Karnofsky 50-100% (, 16 years of age). *Performance status - Lansky 30-100% (≤ 16 years of age) ... To improve compliance with long-term quality of life (QoL) and functional status data submission by educating institutional ...https://clinicaltrials.gov/ct2/show/study/NCT00085735?term=ACNS0331&rank=1&show_desc=Y
Bryostatin 1 Plus Vincristine in Treating Patients With Recurrent or Refractory HIV-Related Lymphoma - Full Text View -...
Performance status - Karnofsky 70-100%. *At least 12 weeks. *Absolute granulocyte count at least 1,000/mm3 ...https://clinicaltrials.gov/show/NCT00022555?order=84
7-Hydroxystaurosporine and Irinotecan Hydrochloride in Treating Patients With Metastatic or Unresectable Solid Tumors or Triple...
Performance status - ECOG 0-2. *Performance status - Karnofsky 60-100%. *More than 12 weeks ... Using the high-performance liquid chromatography (HPLC) assays.. *Serum alpha-acid glycoprotein and correlate this level with ...https://clinicaltrials.gov/ct2/show/NCT00031681?term=Breast+Cancer&lup_s=10%2F31%2F2012&lup_d=30
Lenalidomide in Kaposi Disease Associated With HIV Infection - Full Text View - ClinicalTrials.gov
Karnofsky performance status over 70%. *Social security (State Medical Assistance is not a social security scheme) ...https://clinicaltrials.gov/show/NCT01282047?order=177
Cilengitide (EMD 121974) in Treating Patients With Advanced Solid Tumors or Lymphoma - Full Text View - ClinicalTrials.gov
Performance status - Karnofsky 70-100%. *WBC ≥ 3,000/mm^3. *Absolute neutrophil count ≥ 1,500/mm^3 ...https://clinicaltrials.gov/show/NCT00077155?order=183
Weekly Paclitaxel Plus Carboplatin in Preoperative Treatment of Breast Cancer - Full Text View - ClinicalTrials.gov
Karnofsky performance status (KPS) ≥ 70. *At least one measurable disease according to the RECIST. histologically confirmed ...https://clinicaltrials.gov/ct2/show/NCT01203267
Celecoxib and Radiation Therapy in Treating Patients With Stage II or Stage III Soft Tissue Sarcoma of the Arm, Hand, Leg, or...
Karnofsky performance status 70-100%. *WBC ≥ 3,000/mm³. *Absolute granulocyte count ≥ 1,500/mm³ ...https://clinicaltrials.gov/ct2/show/NCT00450736?cond=%22Dermatofibroma%22&rank=7
Basiliximab in Treating Patients With Newly Diagnosed Glioblastoma Multiforme Undergoing Targeted Immunotherapy and...
Karnofsky performance status 80-100%. *Curran Group status I-IV. *Not pregnant or nursing ...https://clinicaltrials.gov/ct2/show/NCT00626483?term=Lymphocytopenia&recr=Open&fund=01&rank=3
Positron Emission Tomography Using Fluorine F 18 EF5 to Find Oxygen in Tumor Cells of Patients Who Are Undergoing Surgery or...
Performance status - Karnofsky 70-100%. *At least 3 months. *WBC count ≥ 2,000/mm^3 ... Recruitment Status : Terminated (Administratively complete.) First Posted : May 4, 2005. Last Update Posted : January 16, 2013 ...https://clinicaltrials.gov/ct2/show/NCT00110032?cond=%22Anaplastic+oligodendroglioma%22&rank=7
Irinotecan and Thalidomide in Treating Patients With Advanced Solid Tumors - Full Text View - ClinicalTrials.gov
Performance status - Karnofsky 70-100%. *More than 12 weeks. *WBC at least 3,000/mm^3 ...https://clinicaltrials.gov/ct2/show/NCT00062127
Human Papillomavirus Vaccine Therapy in Treating Men With HIV-1 Infection - Full Text View - ClinicalTrials.gov
Karnofsky performance status 70-100%. *Absolute neutrophil count , 750 cells/mm³. *Hemoglobin ≥ 9.0 g/dL ... HPV Antibody Titers to Type 6 at Baseline and Weeks 28 and 76 According to Baseline Seropositive Status [ Time Frame: weeks 0, ... HPV Antibody Titers to Type 11 at Baseline and Weeks 28 and 76 According to Baseline Seropositive Status [ Time Frame: weeks 0 ... HPV Antibody Titers to Type 16 at Baseline and Weeks 28 and 76 According to Baseline Seropositive Status [ Time Frame: weeks 0 ...https://clinicaltrials.gov/show/NCT00513526?order=35
Clofarabine and High-Dose Melphalan Followed by Donor Stem Cell Transplant in Patients With Acute Myeloid Leukemia, Acute...
Karnofsky performance status 50-100%. *Glomerular filtration rate (pediatric patients) or creatinine clearance ≥ 60 mL/min OR ...https://clinicaltrials.gov/ct2/show/NCT00641030
Donor Lymphocyte Infusion in Treating Patients With Recurrent or Persistent Hematologic Cancer After Donor Stem Cell Transplant...
Karnofsky performance status 60-100%. *Life expectancy ≥ 8 weeks. *Creatinine , 3 mg/dL ...https://clinicaltrials.gov/ct2/show/NCT00534118?term=00534118&rank=1
A Randomized, Dose-ranging Study of Alferon LDO in Asymptomatic HIV+ Subjects - Full Text View - ClinicalTrials.gov
Karnofsky performance status of 100. *Subjects must be asymptomatic with regard to HIV related clinical symptoms including the ...https://clinicaltrials.gov/show/NCT00215852?order=228
Manchester score - Wikipedia
Karnofsky performance status less than 60. Extensive stage disease. Cerny, T; Blair V; Anderson H; et al. (1987). "Pretreatment ...https://en.wikipedia.org/wiki/Manchester_score
Performance status - Wikipedia
Buccheri G, Ferrigno D, Tamburini M. Karnofsky and ECOG performance status scoring in lung cancer: a prospective, longitudinal ... Zubrod 0-1 equals Karnofsky 80-100 Zubrod 2 equals Karnofsky 60-70 Zubrod 3-4 equals Karnofsky 10-50 Karnofsky DA, Abelmann WH ... The Karnofsky Performance Score (KPS) ranking runs from 100 to 0, where 100 is "perfect" health and 0 is death. Practitioners ... In medicine (oncology and other fields), performance status is an attempt to quantify cancer patients' general well-being and ...https://en.wikipedia.org/wiki/Performance_status
Metastatic breast cancer - Wikipedia
Karnofsky performance status ≥70) fare best; older patients with a Karnofsky performance status below 70 do poorly. Effective ... although symptomatic therapy alone may be chosen for those with poor performance status. Corticosteroids are crucial to the ... Symptoms of brain metastases from breast cancer are: new-onset headache changes in mental status, cognition and behavior ataxia ... Metastatic breast cancer cells frequently differ from the preceding primary breast cancer in properties such as receptor status ...https://en.wikipedia.org/wiki/Metastatic_breast_cancer
Renal cell carcinoma - Wikipedia
... factors which may present a poor prognosis include a low Karnofsky performance-status score (a standard way of measuring ... "The current status of tailor-made medicine with molecular biomarkers for patients with clear cell renal cell carcinoma". ... current status and future perspectives". Expert Review of Anticancer Therapy. 13 (6): 697-709. doi:10.1586/era.13.52. PMID ...https://en.wikipedia.org/wiki/Renal_cell_carcinoma